Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(10)
DRUG(6)
PROCEDURE(1)
Pembrolizumab
2 trials
phase_1phase_1_2
md-anderson-cancer-center
IV Abraxane
2 trials
phase_1
green3bio-inc, md-anderson-cancer-center
Atezolizumab
1 trial
phase_1_2
md-anderson-cancer-center
Plinabulin
1 trial
phase_1_2
md-anderson-cancer-center
Avelumab
1 trial
phase_1_2
md-anderson-cancer-center
Bevacizumab
1 trial
phase_1
md-anderson-cancer-center
ZN-c3
1 trial
phase_1
md-anderson-cancer-center
Hepatic Artery Catheter
1 trial
phase_1
md-anderson-cancer-center

+7 more interventions

15 unique interventions3 categories

Analytics

Trial Phases

Phase 16
Phase 21

Trial Status

Completed1
Terminated1
Other4

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05431582Phase 1Withdrawn
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
Breast CancerLung CancerOvarian Cancer+2 more
PrincipalinvestigatorStart date: 2022-12-14
NCT05300438Phase 1Unknown
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
Cancer (With or Without Metastasis)
PrincipalinvestigatorStart date: 2022-02-18
NCT04902040Phase 1/2Terminated
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
PrincipalinvestigatorStart date: 2021-04-14
NCT04711161Phase 1Suspended
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Ovarian Tumors
PrincipalinvestigatorStart date: 2020-12-21
NCT00732836Phase 1Completed
Hepatic Arterial Infusion (HAI) of Abraxane
Advanced CancersLiver CancerSolid Tumors
Principalinvestigator
NCT02812056Phase 1Withdrawn
Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
Malignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Lip Oral Cavity and Pharynx+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Advanced Renal Cell CarcinomaStage III Lung Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8+7 more
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary CancerCancer of Pancreas+3 more
Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerNeoplasmsBreast Cancer+2 more
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverLung CancerCancer of Pancreas+2 more
Similarity Score3%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of LiverCancer of PancreasBreast Cancer+1 more
Similarity Score2%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerAdvanced Malignant Solid NeoplasmBreast Cancer+1 more
Similarity Score2%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lung CancerBreast CancerOvary Cancer

Worked with same sponsors:

Millennium Pharmaceuticals, Inc.
Similarity Score2%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Ovary CancerSolid TumorsNeoplasms
Similarity Score2%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasBreast CancerLung Cancer
Similarity Score2%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Cancer of LiverCancer of Pancreas
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05431582Phase 1PrincipalInvestigator

Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors

Breast CancerLung CancerOvarian Cancer+2 more
Withdrawn
NCT05300438Phase 1PrincipalInvestigator

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Cancer (With or Without Metastasis)
Unknown
NCT04902040Phase 1/2PrincipalInvestigator

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

Advanced Bladder CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid Neoplasm+32 more
Terminated
NCT04711161Phase 1PrincipalInvestigator

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Ovarian Tumors
Suspended
NCT00732836Phase 1PrincipalInvestigator

Hepatic Arterial Infusion (HAI) of Abraxane

Advanced CancersLiver CancerSolid Tumors
Completed
NCT02812056Phase 1PrincipalInvestigator

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Malignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Lip Oral Cavity and Pharynx+1 more
Withdrawn

All 6 trials loaded